SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-16-057004
Filing Date
2016-03-08
Accepted
2016-03-08 17:00:28
Documents
2
Period of Report
2016-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 5626
2 jvnaardenpoa.htm EX-24 7641
  Complete submission text file 0001140361-16-057004.txt   14624
Mailing Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901
Business Address 1 LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Issuer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LOXO ONCOLOGY, INC. ONE LANDMARK SQUARE, SUITE 1122 STAMFORD CT 06901
Business Address
Van Naarden Jacob (Reporting) CIK: 0001661254 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36562 | Film No.: 161492192